MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 59 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,305,124 | +122.4% | 67,421 | +63.4% | 0.00% | +100.0% |
| Q1 2024 | $1,036,627 | -73.4% | 41,267 | -68.8% | 0.00% | -71.4% |
| Q4 2023 | $3,902,898 | +23.9% | 132,212 | +32.7% | 0.01% | -12.5% |
| Q3 2023 | $3,149,161 | +226.7% | 99,657 | +167.5% | 0.01% | +166.7% |
| Q2 2023 | $963,890 | +227.0% | 37,259 | +146.5% | 0.00% | +200.0% |
| Q4 2022 | $294,782 | -21.2% | 15,117 | -29.5% | 0.00% | -66.7% |
| Q4 2020 | $374,000 | -18.0% | 21,441 | -9.4% | 0.00% | -50.0% |
| Q3 2020 | $456,000 | -16.3% | 23,661 | -15.5% | 0.01% | -33.3% |
| Q2 2020 | $545,000 | +11.7% | 27,987 | -19.7% | 0.01% | -25.0% |
| Q1 2020 | $488,000 | – | 34,866 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |